A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy

BACKGROUND: There are various treatment options for esophageal squamous cell cancer. including surgery, peri-operative chemotherapy, and radiation. More recently, neoadjuvant immunotherapy has also been shown improve outcomes. In this study, we addressed the question, “Can we predict which patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yongkui, Wang, Wei, Qin, Zimin, Li, Haomiao, Liu, Qi, Ma, Haibo, Sun, Haibo, Bauer, Thomas L., Pimiento, Jose M., Gabriel, Emmanuel, Birdas, Thomas, Li, Yin, Xing, Wenqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848421/
https://www.ncbi.nlm.nih.gov/pubmed/35282099
http://dx.doi.org/10.21037/atm-22-78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848421/
https://www.ncbi.nlm.nih.gov/pubmed/35282099
http://dx.doi.org/10.21037/atm-22-78

Ejemplares similares